Novel mitochondria-targeting compounds selectively kill human leukemia cells-Reference-Cited by-同舟云学术

Novel mitochondria-targeting compounds selectively kill human leukemia cells

Published:2022-06-07 Issue:8 Volume:36 Page:2009-2021
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Panina Svetlana B.,Pei Jingqi,Baran Natalia^ORCID,Tjahjono Elissa^ORCID,Patel Shraddha,Alatrash Gheath,Konoplev Sergej,Stolbov Leonid A.,Poroikov Vladimir V.^ORCID,Konopleva Marina^ORCID,Kirienko Natalia V.^ORCID

Funder

U.S. Department of Health & Human Services | NIH | National Cancer Institute

U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences

Cancer Prevention and Research Institute of Texas

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

https://www.nature.com/articles/s41375-022-01614-0.pdf

Reference59 articles.

1. Weinberg F, Hamanaka R, Wheaton WW, Weinberg S, Joseph J, Lopez M, et al. Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity. Proc Natl Acad Sci USA. 2010;107:8788–93.

2. Wise DR, Thompson CB. Glutamine addiction: A new therapeutic target in cancer. Trends Biochem Sci. 2010;35:427–33.

3. Battogtokh G, Cho YY, Lee JY, Lee HS, Kang HC. Mitochondrial-targeting anticancer agent conjugates and nanocarrier systems for cancer treatment. Front Pharm. 2018;9:922.

4. Neagu M, Constantin C, Popescu ID, Zipeto D, Tzanakakis G, Nikitovic D, et al. Inflammation and metabolism in cancer cell-mitochondria key player. Front Oncol. 2019;9:348.

5. Macleod K. Mitophagy and mitochondrial dysfunction in cancer. Annu Rev Cancer Biol. 2020;4:41–60.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing anti-AML activity of venetoclax by isoflavone ME-344 through suppression of OXPHOS and/or purine biosynthesis in vitro;Biochemical Pharmacology;2024-02

2. The Molecular Context of Oxidant Stress Response in Cancer Establishes ALDH1A1 as a Critical Target: What This Means for Acute Myeloid Leukemia;International Journal of Molecular Sciences;2023-05-27

3. Preclinical investigations of the efficacy of the glutaminase inhibitor CB-839 alone and in combinations in chronic lymphocytic leukemia;Frontiers in Oncology;2023-05-09

4. Examining Sporadic Cancer Mutations Uncovers a Set of Genes Involved in Mitochondrial Maintenance;Genes;2023-04-29